CYBeR-CARE Announces Share Repurchase Program.Business Editors/Health & Medical Writers BOYNTON BEACH, Fla.--(BW HealthWire)--Nov. 21, 2000 CYBeR-CARE, Inc. (Nasdaq:CYBR CYBR Copy Byte Right ) announced that its Board of Directors has approved the buy-back of up to 1,000,000 shares of common stock on the open market. Certain officers may also go into the market and buy shares from time to time. Chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. Michael Morrell said, "We believe our shares are undervalued Undervalued A stock or other security that is trading below its true value. Notes: The difficulty is knowing what the "true" value actually is. Analysts will usually recommend an undervalued stock with a strong buy rating. and we view this share repurchase Share Repurchase A program by which a company buys back its own shares from the marketplace, reducing the number of outstanding shares. This is usually an indication that the company's management thinks the shares are undervalued. program as a way to return value to our shareholders." Based in Boynton Beach, FL, CYBeR-CARE is creating an Internet technology-based telehealth network worldwide. In addition, CYBeR-CARE operates physical, occupational and speech therapy centers and an institutional pharmacy. Safe Harbor Statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion